Key result
Minor ESUS shows no significant difference in recurrent stroke risk compared to more severe stroke.
Why the study?
Embolic stroke of undetermined source (ESUS) carries a substantial risk of recurrence, but the clinical correlates of recurrence in East Asian populations remained poorly characterized.
Cohort (n=116)
No
In a small Taiwanese ESUS cohort, recurrent ischemic stroke occurred in 14.7% of patients over a median of 28.4 months, frequently clustering within the first 6 months and in the same arterial territory, though no baseline clinical factors reliably predicted recurrence.
Answers are grounded in this paper and cite their sources.
Recurrence risk in ESUS warrants ongoing clinical vigilance; observational data leaves open optimal secondary prevention strategies.
Background Embolic stroke of undetermined source (ESUS) carries a substantial risk of recurrence, but the clinical correlates of recurrence in East Asian populations remain poorly characterized. We aimed to describe recurrence patterns after ESUS and to explore, in a hypothesis-generating manner, baseline clinical and metabolic factors associated with recurrent stroke. Methods We conducted a single-center retrospective cohort study of 116 consecutive patients hospitalized with ESUS at Fu Jen Catholic University Hospital, Taiwan, between January 2021 and December 2024, with follow-up until December 31, 2025. Associations with recurrent stroke were examined with univariable Cox proportional hazards regression; Fine–Gray competing-risk regression (death as a competing event) and a 12-month logistic analysis were sensitivity analyses. Bayesian sensitivity analyses used conjugate beta–binomial models with Jeffreys priors. Given the small number of events, all analyses were considered descriptive and hypothesis-generating. Results During a median follow-up of 28.4 months, 17 patients (14.7%) had recurrent ischemic stroke; the cumulative incidence was 10.5% at 12 months and 14.0% at 24 months, and half of the recurrences with a known date occurred within 6 months. No baseline variable was significantly associated with recurrence in the primary analysis; with 17 events, odds ratios of approximately 4 to 7 would have been required for 80% power. Recurrence was numerically more frequent after minor index strokes (National Institutes of Health Stroke Scale [NIHSS] ≤ 3: 12/65, 18.5%) than after more severe strokes (5/51, 9.8%), but the estimate was imprecise (hazard ratio 1.58; 95% confidence interval 0.55–4.50). Among recurrent patients whose index infarct was confined to a single arterial circulation, 6 of 9 with assessable imaging recurred within the same circulation. Conclusions In this small ESUS cohort, recurrent stroke was not uncommon, but no baseline characteristic reliably identified patients at higher risk. The early clustering of recurrence, the numerically higher recurrence after minor strokes, and the recurrence topography are hypothesis-generating observations compatible with several explanations, including non-stenotic atherosclerosis, occult atrial fibrillation, differences in treatment and follow-up, and chance. Larger prospective studies with prolonged rhythm monitoring and vessel-wall imaging are needed.
No takes yet. Share an insight, caveat, or question.
Hsu et al. (2026) conducted a cohort in Embolic stroke of undetermined source (ESUS) (n=116). Minor index stroke (NIHSS ≤ 3) vs. More severe index stroke (NIHSS > 3) was evaluated on Recurrent ischemic stroke (HR 1.58, 95% CI 0.55-4.50). Minor index ESUS (NIHSS ≤3) had numerically higher recurrent stroke than more severe stroke, with 14.7% overall recurrence.
Synapse has enriched 10 related papers. Consider them for comparative context: